SCHEMBL7408146

SCHEMBL7408146

COc1cc(CC(=O)O)c(C(=O)c2ccc(-c3ccccc3)cc2)cc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
KMT2A Q03164 2/20 0.52
POLB P06746 1/20 0.52
CASP3 P42574 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
CYP3A4 P08684 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HTT P42858 1/20 0.47
NR1H4 Q96RI1 1/20 0.46
HSD17B10 Q99714 3/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
RECQL P46063 1/20 0.46
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45
CDC25B P30305 1/20 0.45
ATM Q13315 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7433697 0.82 CYP3A4 (0.57) GAANPSR1KMT2APOLBCASP3
SCHEMBL9047484 0.81 CDC25B (0.51) NPSR1KMT2APOLBCYP3A4SMN1; SMN2
SCHEMBL5486180 0.81 CASP3 (0.58) GAANPSR1KMT2APOLBCASP3
SCHEMBL7411516 0.78 TSHR (0.54) NPSR1KMT2APOLBCYP3A4SMN1; SMN2
SCHEMBL16035689 0.77 PTGS1 (0.49) GAAHTTNR1H4LMNACDC25B
SCHEMBL5036095 0.77 NR1H4 (0.52) GAAKMT2AHTTNR1H4HSD17B10
SCHEMBL28521117 0.76 CASP3 (0.56) GAANPSR1KMT2APOLBCASP3
SCHEMBL2339398 0.76 GAA (0.63) GAANPSR1KMT2ACYP3A4HTT
SCHEMBL7438219 0.76 MAPT (0.67) GAANPSR1KMT2ACASP3SENP6
SCHEMBL1010387 0.75 CYP1A2 (0.73) GAACYP3A4SMN1; SMN2MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002088096-A1 COMPOUNDS INHIBITING CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, PREPARATION AND USES THEREOF NEURO3D (FR) 2002-11-07 WO disclosed
EP-0981521-A2 NOVEL MACROCYCLIC COMPOUNDS AS METALLOPROTEASE INHIBITORS Dupont Pharmaceuticals Company (US) 2000-03-01 EP disclosed
WO-1998051665-A2 NOVEL MACROCYCLIC COMPOUNDS AS METALLOPROTEASE INHIBITORS DUPONT PHARMACEUTICALS COMPANY (US) 1998-11-19 WO disclosed